According to the FDA, Official Action Indicated means regulatory and/or administrative actions will be recommended against a facility after an inspection.
USFDA recommends regulatory action after Jubilant Life’s Roorkee plant inspection
More from Industry NewsMore posts in Industry News »
- India tops the chart for approved biosimilars and clinical trials surpassing USA and Europe: 10th Annual Pharma IPR India Conference
- India initiates antidumping probe on certain type of steel from Brazil, China, Germany
- BDR Pharma receives DGCI nod for its generic drug BIAPENEM
- AstraZeneca invests in Imperial’s self-amplifying RNA technology with eye on future drugs